4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Peptidoglycan editing provides immunity to Acinetobacter baumannii during bacterial warfare

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A peptidoglycan editing mechanism confers protection against T6SS assaults without relying on immunity proteins.

          Abstract

          Peptidoglycan (PG) is essential in most bacteria. Thus, it is often targeted by various assaults, including interbacterial attacks via the type VI secretion system (T6SS). Here, we report that the Gram-negative bacterium Acinetobacter baumannii strain ATCC 17978 produces, secretes, and incorporates the noncanonical d-amino acid d-lysine into its PG during stationary phase. We show that PG editing increases the competitiveness of A. baumannii during bacterial warfare by providing immunity against peptidoglycan-targeting T6SS effectors from various bacterial competitors. In contrast, we found that d-Lys production is detrimental to pathogenesis due, at least in part, to the activity of the human enzyme d-amino acid oxidase (DAO), which degrades d-Lys producing H 2O 2 toxic to bacteria. Phylogenetic analyses indicate that the last common ancestor of A. baumannii had the ability to produce d-Lys. However, this trait was independently lost multiple times, likely reflecting the evolution of A. baumannii as a human pathogen.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Peptidoglycan structure and architecture.

          The peptidoglycan (murein) sacculus is a unique and essential structural element in the cell wall of most bacteria. Made of glycan strands cross-linked by short peptides, the sacculus forms a closed, bag-shaped structure surrounding the cytoplasmic membrane. There is a high diversity in the composition and sequence of the peptides in the peptidoglycan from different species. Furthermore, in several species examined, the fine structure of the peptidoglycan significantly varies with the growth conditions. Limited number of biophysical data on the thickness, elasticity and porosity of peptidoglycan are available. The different models for the architecture of peptidoglycan are discussed with respect to structural and physical parameters.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Uncovering the mechanisms of Acinetobacter baumannii virulence

            Acinetobacter baumannii is a nosocomial pathogen that causes ventilator-associated as well as bloodstream infections in critically ill patients, and the spread of multidrug-resistant Acinetobacter strains is cause for concern. Much of the success of A. baumannii can be directly attributed to its plastic genome, which rapidly mutates when faced with adversity and stress. However, fundamental virulence mechanisms beyond canonical drug resistance were recently uncovered that enable A. baumannii and, to a limited extent, other medically relevant Acinetobacter species to successfully thrive in the health-care environment. In this Review, we explore the molecular features that promote environmental persistence, including desiccation resistance, biofilm formation and motility, and we discuss the most recently identified virulence factors, such as secretion systems, surface glycoconjugates and micronutrient acquisition systems that collectively enable these pathogens to successfully infect their hosts.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Type VI secretion delivers bacteriolytic effectors to target cells

              Peptidoglycan is the major structural constituent of the bacterial cell wall, forming a meshwork outside the cytoplasmic membrane that maintains cell shape and prevents lysis. In Gram-negative bacteria, peptidoglycan is located in the periplasm, where it is protected from exogenous lytic enyzmes by the outer membrane. Here we show that the type VI secretion system (T6SS) of Pseudomonas aeruginosa breaches this barrier to deliver two effector proteins, Tse1 and Tse3, to the periplasm of recipient cells. In this compartment, the effectors hydrolyze peptidoglycan, thereby providing a fitness advantage for P. aeruginosa cells in competition with other bacteria. To protect itself from lysis by Tse1 and Tse3, P. aeruginosa utilizes specific periplasmically-localized immunity proteins. The requirement for these immunity proteins depends on intercellular self-intoxication through an active T6SS, indicating a mechanism for export whereby effectors do not access donor cell periplasm in transit.
                Bookmark

                Author and article information

                Journal
                Sci Adv
                Sci Adv
                SciAdv
                advances
                Science Advances
                American Association for the Advancement of Science
                2375-2548
                July 2020
                22 July 2020
                : 6
                : 30
                : eabb5614
                Affiliations
                [1 ]Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
                [2 ]Centre for Bacterial Cell Biology, Biosciences Institute, Newcastle University, NE2 4AX Newcastle upon Tyne, UK.
                [3 ]Laboratory for Molecular Infection Medicine Sweden, Department of Molecular Biology, Umeå Centre for Microbial Research, Umeå University, 90187 Umeå, Sweden.
                [4 ]Department of Pathology, Microbiology, and Immunology and Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
                [5 ]Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
                [6 ]Applied Bioinformatics Group, Institute of Cell Biology and Neuroscience, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
                [7 ]Department of Biology, Washington University in St. Louis, St. Louis, MO 63105, USA.
                [8 ]LOEWE Center for Translational Biodiversity Genomics (TBG), Senckenberganlage 25, D-60325 Frankfurt am Main, Germany.
                [9 ]Senckenberg Biodiversity and Climate Research Center (S-BIKF), Senckenberganlage 25, D-60325 Frankfurt am Main, Germany.
                Author notes
                [* ]Corresponding author. Email: mariofeldman@ 123456wustl.edu .
                Author information
                http://orcid.org/0000-0001-8659-6949
                http://orcid.org/0000-0002-1413-9404
                http://orcid.org/0000-0003-2338-0301
                http://orcid.org/0000-0003-1969-3145
                http://orcid.org/0000-0002-3433-2412
                http://orcid.org/0000-0002-6066-8315
                http://orcid.org/0000-0001-5482-6551
                http://orcid.org/0000-0003-2071-0547
                http://orcid.org/0000-0001-8187-9253
                http://orcid.org/0000-0001-5094-8105
                http://orcid.org/0000-0001-5995-718X
                http://orcid.org/0000-0003-4497-0976
                Article
                abb5614
                10.1126/sciadv.abb5614
                7439305
                32832672
                898f55af-4c60-4b7e-b35d-cce04890f6e4
                Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

                History
                : 03 March 2020
                : 09 June 2020
                Funding
                Funded by: doi http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
                Award ID: R21 AI137188
                Categories
                Research Article
                Research Articles
                SciAdv r-articles
                Immunology
                Microbiology
                Microbiology
                Custom metadata
                Lou Notario

                Comments

                Comment on this article